NDC Package 50242-917-86 Tecentriq

Atezolizumab Injection, Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
50242-917-86
Package Description:
1 VIAL, SINGLE-USE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-USE
Product Code:
Proprietary Name:
Tecentriq
Non-Proprietary Name:
Atezolizumab
Substance Name:
Atezolizumab
Usage Information:
This medication is used to treat various cancers (such as bladder, breast, liver, lung, skin). It works by helping your immune system fight the cancer. Atezolizumab belongs to a class of drugs known as monoclonal antibodies.
11-Digit NDC Billing Format:
50242091786
NDC to RxNorm Crosswalk:
  • RxCUI: 1792780 - atezolizumab 1200 MG in 20 ML Injection
  • RxCUI: 1792780 - 20 ML atezolizumab 60 MG/ML Injection
  • RxCUI: 1792780 - atezolizumab 1200 MG per 20 ML Injection
  • RxCUI: 1792785 - Tecentriq 1200 MG in 20 ML Injection
  • RxCUI: 1792785 - 20 ML atezolizumab 60 MG/ML Injection [Tecentriq]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Genentech, Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    Yes
    FDA Application Number:
    BLA761034
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    05-18-2016
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    50242-917-011 VIAL, SINGLE-USE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-USE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 50242-917-86?

    The NDC Packaged Code 50242-917-86 is assigned to a package of 1 vial, single-use in 1 carton / 20 ml in 1 vial, single-use of Tecentriq, a human prescription drug labeled by Genentech, Inc.. The product's dosage form is injection, solution and is administered via intravenous form.

    Is NDC 50242-917 included in the NDC Directory?

    Yes, Tecentriq with product code 50242-917 is active and included in the NDC Directory. The product was first marketed by Genentech, Inc. on May 18, 2016 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 50242-917-86?

    The 11-digit format is 50242091786. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-250242-917-865-4-250242-0917-86